USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
HEMOGENIX, LLC
Address:
HEMOGENIX, LLC
GREENWOOD GENETIC CTR
GREENWOOD, SC 29646
Phone:
(864) 388-1818
URL:
N/A
EIN:
571093800
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $120,000.00 2
SBIR Phase II $926,630.00 1

Award List:

AN IN VITRO HIGH THROUGHPUT STEM CELL HEMOTOXICITY ASSAY

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$120,000.00
Agency:
HHS
Principal Investigator:
Ivan N. Rich
Abstract:
Present hemotoxicity testing during drug development has a low predictability level. In contrast, the in vitro hematopoietic stem and progenitor cell colony-forming assays (CFA) provide validated and highly predictive procedures which can be extrapolated to other proliferating cell systems and are… More

An In Vitro Throughput Stem Cell Hemotoxicity Assay

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Conventional hemotoxicity testing, performed primarily during the preclinical phase of drug development, is based on parameters obtained from mature cells in peripheral blood or organ morphology and, as such, has little predictive value. The in vitro… More

An In Vitro Throughput Stem Cell Hemotoxicity Assay

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$926,630.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Conventional hemotoxicity testing, performed primarily during the preclinical phase of drug development, is based on parameters obtained from mature cells in peripheral blood or organ morphology and, as such, has little predictive value. The in vitro… More